References
-
1) SPC25 as a novel therapeutic and prognostic biomarker and its association with glycolysis, ferroptosis and ceRNA in lung adenocarcinoma.
Product: SPC25 Antibody (#DF13747)Year: 2024Journal: Aging (Albany NY)DOI: 10.18632/aging.205418PMID: 38217547 -
2) Generation of a TBX5 homozygous knockout embryonic stem cell line (WAe009-A-45) by CRISPR/Cas9 editing.
Product: TBX5 Antibody (#DF13705)Year: 2021Journal: STEM CELL RESImpactFactor: 1.2DOI: 10.1016/j.scr.2021.102156PMID: 33497883 -
3) GRIM19 deficiency aggravates metabolic disorder and ovarian dysfunction in PCOS.
Year: 2024Journal: Biochim Biophys Acta Mol Basis DisImpactFactor: 6.2DOI: 10.1016/j.bbadis.2024.167063PMID: 38360073 -
4) Calycosin inhibited autophagy and oxidative stress in chronic kidney disease skeletal muscle atrophy by regulating AMPK/SKP2/CARM1 signalling pathway.
Product: CARM1 Antibody (#DF13699)Year: 2020Journal: J CELL MOL MEDImpactFactor: 5.3DOI: 10.1111/jcmm.15514PMID: 32910538 -
5) RABL2A–CCDC34 Axis Promotes Sorafenib Resistance in Hepatocellular Carcinoma.
Product: CCDC34 Antibody (#DF13697)Year: 2021Journal: DNA CELL BIOLImpactFactor: 3.1DOI: 10.1089/dna.2021.0473PMID: 34767735 -
6) PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor.
Product: UNC5B Antibody (#DF13685)Year: 2022Journal: THERANOSTICSImpactFactor: 12.4DOI: 10.7150/thno.71100PMID: 35664063 -
7) Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Product: CARD12 Antibody (#DF13673)Year: 2022Journal: Front ImmunolImpactFactor: 7.3DOI: 10.3389/fimmu.2022.1062225PMID: 36605187 -
8) LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer.
Product: NLRC5 Antibody (#DF13672)Year: 2022Journal: CANCER LETTImpactFactor: 9.7DOI: 10.1016/j.canlet.2021.12.031PMID: 34974132 -
9) Pathological changes and expression of lysine oxidases and matrix metalloproteinases‐1,‐2, and‐3 in ligaments of patients with haemophilic arthritis.
Product: LOXL4 Antibody (#DF13661)Year: 2022Journal: HAEMOPHILIAImpactFactor: 3.9DOI: 10.1111/hae.14443PMID: 34697874 -
10) Novel long non‐coding RNA CYB561‐5 promotes aerobic glycolysis and tumorigenesis by interacting with basigin in non‐small cell lung cancer.
-
11) Therapeutic effects of quinine in a mouse model of atopic dermatitis.
Product: Filaggrin Antibody (#DF13653)Year: 2021Journal: MOL MED REPImpactFactor: 3.4DOI: 10.3892/mmr.2021.11952PMID: 34240224 -
12) Glutamine‐based Metabolism Normalization and Oxidative Stress Alleviation by Self‐assembled bilirubin/V9302 Nanoparticles for Psoriasis Treatment.
Product: SLC1A5 Antibody (#DF13643)Year: 2023Journal: ADV HEALTHC MATERImpactFactor: 10DOI: 10.1002/adhm.202203397PMID: 36690435 -
13) Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy.
Product: ILF1 Antibody (#DF13638)Year: 2023Journal: ONCOTARGETS THERImpactFactor: 4DOI: 10.2147/OTT.S255956PMID: 32982306 -
14) Anti-Tim4 Grafting Strongly Hydrophilic Metal–Organic Frameworks Immunoaffinity Flake for High-Efficiency Capture and Separation of Exosomes.
Product: TIM 4 Antibody (#DF13636)Year: 2021Journal: Anal. Chem.ImpactFactor: 7.4DOI: 10.1021/acs.analchem.1c00528PMID: 33851819 -
15) Identification by RNA-Seq of let-7 clusters as prenatal biomarkers for nonsyndromic cleft lip with palate.
Product: Hhip Antibody (#DF13634)Year: 2022Journal: Ann N Y Acad SciImpactFactor: 5.2DOI: 10.1111/nyas.14868PMID: 35854669